<DOC>
	<DOCNO>NCT00166816</DOCNO>
	<brief_summary>The purpose study understand pharmacokinetic sirolimus different regimen , well dose-level relationship cyclosporine tacrolimus , design appropriate cyclosporine/sirolimus/steroid tacrolimus/sirolimus/steroid dose regimen Taiwanese .</brief_summary>
	<brief_title>The Pharmacokinetics Sirolimus When Combined With Cyclosporine Tacrolimus Renal Transplant Patients</brief_title>
	<detailed_description>The dose pharmacokinetic immunosuppressant may differ different ethnic , different combination . The purpose study determine dose-level relationship sirolimus pharmacokinetic study . The dose-level relationship cyclosporine tacrolimus also assess . From clinical outcome blood level sirolimus cyclosporine tacrolimus , design appropriate cyclosporine/sirolimus/steroid tacrolimus/sirolimus/steroid dose regimen Taiwanese .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>De novo kidney transplantation patient , age 13－65 year , aminotransferase concentration within 2 time upper limit normal . pregnancy , tuberculosis , hepatitis B C carrier status , human immunodeficiency virus－positive status , retransplantation multiorgan transplantation , history rheumatoid arthritis .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2001</verification_date>
	<keyword>Sirolimus</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Immunosuppressive Agents</keyword>
	<keyword>Immunosuppression</keyword>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Transplantation</keyword>
</DOC>